Related Experiment Videos
An integrated digital microfluidic lab-on-a-chip for clinical diagnostics on human physiological fluids
Vijay Srinivasan1, Vamsee K Pamula, Richard B Fair
1Department of Electrical Engineering, Duke University, 130 Hudson Hall, Durham, NC 27708, USA. vijay@ee.duke.edu
Lab on a Chip
|July 23, 2004
Summary
This study introduces a reconfigurable digital microfluidic lab-on-a-chip for clinical diagnostics using electrowetting. The system successfully manipulates various physiological fluids and performs glucose assays on real samples.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Analytical Chemistry
Background:
- Microfluidic lab-on-a-chip systems offer promise for point-of-care clinical diagnostics.
- Conventional continuous-flow microfluidics lack reconfigurability and scalability for real-world samples.
- Handling diverse human physiological fluids presents a significant challenge for current microfluidic devices.
Purpose of the Study:
- To present a novel, reconfigurable droplet-based digital microfluidic lab-on-a-chip system.
- To demonstrate the compatibility of various human physiological fluids with the electrowetting platform.
- To validate the system's feasibility for performing quantitative bioassays on real clinical samples.
Main Methods:
- Utilized electrowetting for microdroplet manipulation on a digital microfluidic platform.
- Tested compatibility with human whole blood, serum, plasma, urine, saliva, sweat, and tears.
- Performed colorimetric enzymatic glucose assays on serum, plasma, urine, and saliva.
Main Results:
- Demonstrated reliable, high-speed transport of diverse microdroplets of physiological fluids.
- Achieved comparable glucose concentration results to reference methods for serum, plasma, and saliva.
- Identified uric acid interference in urine samples, leading to significant concentration differences.
Conclusions:
- The developed digital microfluidic system is compatible with a wide range of physiological fluids.
- The platform shows feasibility for automated, integrated clinical diagnostics at the point-of-care.
- Further development is needed to address matrix effects, such as interference from uric acid in urine.